Biomedical Engineering Reference
In-Depth Information
[129] Cao L, Liu Y, During M, Xiao W. High-titer wild-type free recombinant adenoas-
sociated virus vector production using intron-containing helper plasmids. J Virol
2000;74:11456-63.
[130] Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, et al.
Recombinant adeno-associated virus purification using novel methods improves infec-
tious titer and yield. Gene Ther 1999;6:973-85.
[131] Hermans WT, ter Brakke O, Dijkhuisen A, Sonnemans MA, Grimm D, Kleinschmidt
JA, et al. Purification of recombinant adeno-associated virus by iodixonal gradient
ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene
transfer in the nervous system. Hum Gene Ther 1999;10:1885-91.
[132] Tamayose K, Hirai Y, Shimada T. A new strategy for large-scale preparation of high
titer recombinant adeno-associated virus vectors by using packaging cell lines and sul-
fonated cellulose column chromatography. Hum Gene Ther 1996;7:507-13.
[133] Clark RW, Liu X, McGrath JP, Johnson PR. Highly purified recombinant adenoassoci-
ated virus vectors are biologically active and free of detectable helper and wild type
viruses. Hum Gene Ther 1999;10:1031-9.
[134] Gao G, Gu G, Burnhan MS, Huang J, Chirmule N, Joshi B, et al. Purification of recom-
binant adeno-associated virus vectors by column chromatography and its performance
in vivo
. Hum Gene Ther 2000;11:2079-91.
[135] Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the tran-
sition from hyperplasia to neoplasia. Nature 1989;339:58-61.
[136] Ma HI, Guo P, Li J. Suppression of intracranial human glioma growth after intramus-
cular administration of an adeno-associated viral vector expressing angiostatin. Cancer
Res 2002;62:756-63.
[137] Xu R, Sun X, Tse LY. Long-term expression of angiostatin suppresses metastatic liver
cancer in mice. Hepatology 2003;37:1451-60.
[138] Ponnazhagan S, Mahendra G, Kumar S. Adeno-associated virus 2-mediated antiangio-
genic cancer gene therapy: long-term efficacy of a vector encoding ngiostatin and end-
ostatin over vectors encoding a single factor. Cancer Res 2004;64:1781-7.
[139] Wendtner CM, Kofler DM, Theiss HD. Efficient gene transfer of CD40 ligand into pri-
mary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors. Blood
2002;100:1655-61.
[140] Dumon KR, Ishii H, Vecchione A. Fragile histidine triad expression delays tumor devel-
opment and induces apoptosis in human pancreatic cancer. Cancer Res 2001;61:4827-36.
[141] Su H, Chang JC, Xu SM, Kan YW. Selective killing of AFP-positive hepatocellular car-
cinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine
kinase gene. Hum Gene Ther 1996;7:463-70.
[142] Okada H, Miyamura K, Itoh T. Gene therapy against an experimental glioma using ade-
noassociated virus vectors. Gene Ther 1996;3:957-64.
[143] Wang AY, Peng PD, Ehrhardt E, Storm TA, Kay MA. Comparison of adenoviral and
adeno-associated viral vectors for pancreatic gene delivery
in vivo
. Hum Gene Ther
2004;15:405-13.
[144] Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, et al.
Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector
neuropeptide y expression in the rat hippocampus. J Neurosci 2004;24:3051-9.
[145] Shen Y, Muramatsu SI, Ikeguchi K, Fujimoto KI, Fan DS, Ogawa M, et al. Triple trans-
duction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-
l-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's
disease. Hum Gene Ther 2000;11:1509-19.
Search WWH ::
Custom Search